Pharmaceutical Dosage Forms and Drug Delivery: Revised and Expanded

About Ajit S. NarangRam I. MahatoVirender Kumar

Ram I. Mahato is Parke-Davis Endowed Professor and Chairman of the Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center Omaha NE. He was a professor at the University of Tennessee Health Science Center in Memphis Research Assistant Professor at the University of Utah in Salt Lake City Senior Scientist at GeneMedicine Inc. The Woodlands TX and as a postdoctoral fellow at the University of Southern California in Los Angeles Washington University in St. Louis and Kyoto University Japan. He received PhD in Drug Delivery from the University of Strathclyde and BSPS from China Pharmaceutical University. He has published 168 papers 17 book chapters holds 4 US patents and has edited/written 12 books and 14 journal issues (Total Google Citations= 14609 and h-Index =70). He was a Feature Editor of the Pharmaceutical Research (2006-2013) and Editorial Board Member of eight journals. He is a CRS and AAPS Fellow Permanent Member of BTSS/NIH Study section and ASGCT Scientific Advisor. He is applying sound principles in pharmaceutical sciences in the context of the latest advances in life and material sciences to solve challenging drug delivery problems in therapeutics.Ajit S. Narang works as a Vice President at Oric Pharmaceuticals in South San Francisco CA. His primary expertise is in oral drug delivery. He holds over 18 years of pharmaceutical industry experience in the development of oral dosage forms and drug delivery platforms. Previously he worked as a Principal Scientist at Genentech Inc. and Bristol-Myers Squibb Co. (BMS) in New Brunswick NJ in the Drug Product Science & Technology Department. In addition to BMS he has worked for Ranbaxy Research Labs (currently a subsidiary of Daiichi Sankyo Japan) and Morton Grove Pharmaceuticals (currently Wockhardt USA). He holds undergraduate Pharmacy degree from the University of Delhi India and graduate degrees in Pharmaceutical Sciences from Banaras Hindu University India and the University of Tennessee Health Science Center (UTHSC) in Memphis TN. He currently serves the Excipient Focus Group chair-elect for the American Association of Pharmaceutical Scientists (AAPS) Adjunct Faculty for the UTHSC and Associate Faculty for the University of Phoenix AZ. His current research interests include innovations in dosage form development and drug delivery technologies that enable pharmaceutical development of challenging molecules to resolve stability pharmacokinetic and pharmacodynamic issues. He has more than 40 publications and three pending patent applications and has contributed to the development of several marketed drug products.Virender Kumar is an assistant professor of Pharmaceutics in the College of Pharmacy and Pharmaceutical Sciences at the University of Toledo Medical Center. He worked as a Research Assistant Professor and as a postdoctoral at the University of Nebraska Medical Center Omaha. He received his PhD in Drug Delivery also from the UNMC. He worked as a scientist in A&Z Pharmaceuticals New York NY. He received a master in industrial pharmacy from Saint Johns University NY. He also received M. Pharm and B. Pharm from Guru Jambheshwar University Hisar Haryana India. He has published 43 papers 6 book chapters holds 1 US patent and has edited/written 1 book and two journal issues.